IMPORTANT SAFETY INFORMATION
Who should not take UBRELVY® (ubrogepant)?
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.

What should I tell my healthcare provider before taking UBRELVY?
Tell your healthcare provider about all your medical conditions, including if you:

  • Have liver problems
  • Have kidney problems
  • Are pregnant or plan to become pregnant
  • Are breastfeeding or plan to breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.

What are the most common side effects of UBRELVY?
The most common side effects are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.

What is UBRELVY?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.

Please see full Patient Information.

We know migraine attacks are more than just a bad headache.

Most people had quick pain relief and some even had pain freedom within 2 hours. UBRELVY® can provide treatment without having to worry if it’s too late* to take it or where you are.

*People took UBRELVY within 4 hours of a migraine attack.

ARE YOU READY FOR A DIFFERENT MIGRAINE TREATMENT?

Think about what’s working or not working with your current migraine treatment plan.

Speak with a healthcare provider online to discuss your migraine symptoms and if UBRELVY is right for you.

Do you ever hesitate to take your migraine medication?

Do you wait to see if it’s a bad migraine before taking your prescription medication?

Does your medication work, even if you don’t take it right away?

Do you ever question if you should take it, depending on where you are or what you’re doing?

about ubrelvy—faqs

taking ubrelvy—faqs

UBRELVY— #1 PRESCRIBED BRANDED TREATMENT FOR MIGRAINE ATTACKS

UBRELVY is the first in a different class of medications for the acute treatment of migraine.

Pill IconA NON-NARCOTIC PILL

UBRELVY® migraine attack treatment for adults packetUBRELVY is specifically designed to treat migraine pain and most debilitating symptoms, which include light sensitivity, sound sensitivity, or nausea.

Based on retail and nonretail monthly prescription data from IQVIA on a 6-month rolling basis as of 06/21.

Ask your healthcare provider about UBRELVY

Stethoscope icon

Find a healthcare provider near you and schedule an appointment to discuss adding UBRELVY to your migraine management toolbox.

Doctor discussion guide icon

Check out this conversation starter for tips on how to get the conversation started on UBRELVY and your current migraine treatment plan.

Browsing with your symptoms in mind

Turn on to enjoy a more migraine-friendly experience.

IMPORTANT SAFETY INFORMATION
Who should not take UBRELVY® (ubrogepant)?
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.

What should I tell my healthcare provider before taking UBRELVY?
Tell your healthcare provider about all your medical conditions, including if you:

  • Have liver problems
  • Have kidney problems
  • Are pregnant or plan to become pregnant
  • Are breastfeeding or plan to breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.

What are the most common side effects of UBRELVY?
The most common side effects are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.

What is UBRELVY?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.

Please see full Patient Information.